0
0
Read Time:6 Second
Medicare has reached a preliminary decision to cover Biogen’s Alzheimer’s drug, Aduhelm, for patients who are in approved clinical trials.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %